Skip to main content

Materialise

SoftwareLeuven, BelgiumFounded 1990· One of 361 Software companies tracked by AMPulse

Collaborative additive manufacturing (CO-AM) software platform for industrial production combined with contract 3D printing services and custom orthopedic/dental medical devices, enabling workflows from design through quality control.

CEO / Founder
Brigitte de Vet-Veithen (since January 1, 2024)
Team Size
1001-5000
Stage
Active
Total Funding
$96M
Latest Round
IPO - $96M - June 2014
Key Investors
Wilfried Vancraen; Hilde Ingelaere; Public Markets

Technology & Products

Key Products

CO-AM Professional: Business-wide collaboration, centralized 3D file management, Magics data preparation automation; CO-AM NPI: Design-of-Experiments, toolpath engineering optimization, layer image analysis for process development; CO-AM Enterprise: End-to-end production control, compliance tracking, traceability; CO-AM Brix: Low-code automation and SDK environment for custom workflows; Magics: Industry-standard data repair and preparation software; 3-matic: Advanced CAD/engineering tool for scan-to-part workflows; Anatomical Data Mining (ADaM): AI-powered population-based anatomical insights for orthopedic/medical device development; Contract 3D printing services: Metal (titanium, aluminum, stainless steel), polymers (nylon, resin), rapid prototyping; Custom orthopedic & dental implants: Patient-specific and anatomically optimized devices

Technological Advantage

Magics is the industry-standard for data preparation (defensible through user base lock-in and data ecosystem). CO-AM ecosystem positions Materialise as an operating system for AM, similar to how PDM software works for traditional CAD. Medical segment provides regulatory moat (FDA approvals) and recurring device sales. Integrated software + manufacturing services enables superior customer outcomes vs. point solutions.

Differentiation

Value Proposition

Reduce time-to-market for custom parts by 70–80% (from 14 weeks to 3 days for aerospace brackets); lower production costs by 30–40% vs. traditional manufacturing; achieve regulatory compliance and production traceability with CO-AM Enterprise; accelerate medical device development with anatomical AI (ADaM) and automated process optimization.

How They Differentiate

Materialise's primary differentiation vs. hardware manufacturers (Stratasys, 3D Systems, Desktop Metal) is platform-agnostic software (works with any printer vendor) and deep manufacturing/medical expertise. vs. contract manufacturers (Protolabs, Shapeways): integrated software + services; medical device regulatory expertise (FDA). vs. software vendors (Autodesk): proprietary Magics ecosystem and decades of embedded domain knowledge in AM workflow optimization.

Market & Competition

Target Customers

Industrial manufacturers, aerospace OEMs, medical device companies, dental laboratories, contract manufacturers pursuing high-mix low-volume and series production

Industry Verticals

Aerospace & Defense (structural components, brackets, engine parts); Automotive (lightweighting, custom tooling, interior trim); Medical Devices (orthopedic implants, dental prosthetics, surgical guides); Consumer & Professional (customized products, jewelry); Industrial Manufacturing (prototyping, low-volume production)

Competitors

Stratasys / 3D Systems (software + hardware manufacturer, competing in services and medical); Desktop Metal (hardware + software + services, competing in manufacturing and dental); Protolabs (contract manufacturing services, broader portfolio including CNC); Autodesk / Netfabb (software competitor, acquired by Autodesk, competing in workflow); GE Additive (software and services, competing in industrial manufacturing)

Growth & Milestones

Growth Metrics

2024 full-year revenue €65.7M (+4.15% YoY); 2025 Q1 revenue €66.4M (+4.3% YoY), Materialise Medical segment +18.7%; 2025 Q2 Medical segment +17% YoY; TTM (May 2025) $290M USD; Materialise Medical is fastest-growing segment.

Major Milestones

Founded 1990 (rapid prototyping service provider, University of Leuven spin-off); IPO June 2014 (NASDAQ: MTLS, €8M shares at $12/ADS, raised ~$96M); Launched CO-AM software platform (2024–2025); Brigitte de Vet-Veithen appointed CEO January 2024; Introduced CO-AM Brix low-code automation tool (Formnext 2025)

Notable Customers

Aerospace OEMs (unnamed in sources, implied by aerospace-focused marketing); Kapstone Medical (orthopedic devices); Global Orthopaedic Technology (APEX implants); Cooksongold (jewelry/precious metals); Various industrial manufacturers and dental laboratories